GTCR-Surmodics Would Harm Medical Device Market, FTC Says
The Federal Trade Commission (FTC) has filed a lawsuit to block the acquisition of Surmodics Inc. by private equity firm GTCR. The FTC argues that the proposed merger would harm competition in the medical-device coatings market, which is crucial for life-saving technologies. Surmodics and GTCR are the two largest providers of medical-device coatings, which are used to improve the performance and safety of various medical devices. The FTC believes that the merger would create a dominant player in the market, leading to higher prices and reduced innovation. The FTC has presented its case in a trial, stating that the deal would eliminate important competition and reduce options for medical device manufacturers. The agency is seeking to block the acquisition to maintain a competitive market and ensure that patients have access to the best possible medical technologies.
Note: This is an AI-generated summary of the original article. For the full story, please visit the source link below.
